Bank of New York Mellon
CELU icon

Bank of New York Mellon’s Celularity CELU Stock Holding History

Bank of New York Mellon’s Portfolio CELU Stock Details CELU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,930
Closed -$7.25K – 4183
2023
Q4 		$7.25K Hold
2,930
– – ﹤0.01% 4282
2023
Q3 		$6.51K Hold
2,930
– – ﹤0.01% 4321
2023
Q2 		$15.6K Sell
2,930
-17,291
-86% -$111K ﹤0.01% 4310
2023
Q1 		$125K Sell
20,221
-496
-2% -$3.99K ﹤0.01% 4036
2022
Q4 		$267K Buy
20,717
+1,604
+8% +$29.6K ﹤0.01% 3845
2022
Q3 		$442K Buy
19,113
+16,502
+632% +$501K ﹤0.01% 3631
2022
Q2 		$89K Buy
+2,611
New +$212K ﹤0.01% 4248

Other funds holding CELU

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CAM
Cresset Asset Management Chicago, Illinois $27.6B AUM 31.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HWM
HB Wealth Management Atlanta, Georgia $17.8B AUM 24.16% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
IIA
IPG Investment Advisors San Diego, California $696M AUM 46.48% 1-Year Est. Return

Bank of New York Mellon's CELU Position: Q1 2024 in Review

Bank of New York Mellon sold out of Celularity (CELU) in Q1 2024, closing a stake of 2,930 shares — an estimated $7.25K sold.

Bank of New York Mellon first reported a position in CELU in Q2 2022 and held it in 7 quarters. The position peaked at $442K in Q3 2022. 30 funds tracked by Wall St. Rank hold CELU as of Q1 2024.

  • Bank of New York Mellon reported no remaining Celularity position as of Q1 2024 after selling out during the quarter.
  • Bank of New York Mellon sold 2,930 Celularity shares in Q1 2024, an estimated $7.25K.
  • Bank of New York Mellon first reported a position in Celularity in Q2 2022 and held it in 7 quarters.
  • Bank of New York Mellon's Celularity position peaked at $442K in Q3 2022.
  • 30 funds tracked by Wall St. Rank held Celularity as of Q1 2024.

Based on Bank of New York Mellon's 13F filing for Q1 2024, filed 25 Apr 2024.